Earnings History Data for Assertio Holdings, Inc. (ASRT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Assertio Holdings, Inc.

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-05-2022	AH	4:00 PM ET (May 9)	ASRT	Assertio Holdings, Inc.	95.20	0.20	0.09	0.12	Assertio Therapeutics Non-GAAP EPS of $0.38, revenue of $36.54M beats by $3.48M [5/9/2022 4:39 PM]	2.20	0.32 (17.02%)	2.12	0.24 (12.77%)	0.85 - 3.52	1,851,024	540,000	86,699
Assertio Therapeutics Non-GAAP EPS of $0.38, revenue of $36.54M beats by $3.48M [5/9/2022 4:39 PM] Assertio Reports First Quarter 2022 Financial Results [May-09-22 04:01PM] Assertio (ASRT) Surpasses Q1 Earnings and Revenue Estimates [May-09-22 05:15PM] Sidoti May Virtual Micro Cap Investor Conference [May-10-22 07:00AM]
09-03-2022	PM	6:00 AM ET (Mar 9)	ASRT	Assertio Holdings, Inc.	101.32	0.10	0.12	-0.80	Assertio Therapeutics GAAP EPS of $0.10 misses by $0.02, revenue of $33.33M beats by $2.56M [3/9/2022 8:56 AM]	2.58	0.41 (18.58%)	2.26	0.08 (3.67%)	0.85 - 4.12	863,517	440,000	25,996
Assertio Therapeutics Q4 Earnings Preview [3/8/2022 11:32 AM] Assertio Therapeutics GAAP EPS of $0.10 misses by $0.02, revenue of $33.33M beats by $2.56M [3/9/2022 8:56 AM] Assertio Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-09-22 08:30AM] Assertio (ASRT) Q4 Earnings Lag Estimates [Mar-09-22 09:45AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	ASRT	Assertio Holdings, Inc.	50.72	0.08	-0.04	-0.36	Assertio Therapeutics EPS beats by $0.24, beats on revenue [11/4/2021 4:03 PM]	1.48	0.37 (32.88%)	1.27	0.16 (14.41%)	0.85 - 5.80	13,581,437	1,190,000	3,702,391
Assertio Therapeutics EPS beats by $0.24, beats on revenue [11/4/2021 4:03 PM] Assertio Reports Third Quarter 2021 Financial Results [Nov-04-21 04:01PM] Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates [Nov-04-21 05:45PM] Sidoti Microcap Virtual Conference [Nov-05-21 12:00PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	ASRT	Assertio Holdings, Inc.	58.22	-0.32	-0.08	-1.40	Assertio Therapeutics EPS misses by $0.24, beats on revenue; raises full year guidance [8/5/2021 4:20 PM]	1.25	-0.08 (-6.01%)	1.35	0.02 (1.50%)	1.15 - 5.80	1,069,440	490,000	20,449
Assertio Reports Second Quarter 2021 Financial Results [Aug-05-21 04:01PM]
06-05-2021	AH	4:00 PM ET (May 6)	ASRT	Assertio Holdings, Inc.	91.39	0.03	-0.01	0.58	Assertio Therapeutics EPS beats by $0.04, beats on revenue [5/6/2021 4:31 PM]	0.57	0.07 (14.30%)	0.62	0.12 (24.32%)	0.33 - 1.45	21,032,676	4,530,000	11,001,241
Assertio Therapeutics EPS beats by $0.04, beats on revenue [5/6/2021 4:31 PM] Assertio shares rise on Q1 revenue strength, provides FY forecast [5/7/2021 11:28 AM] Assertio Holdings, Inc. Partners with Cove, a Leading Migraine Telemedicine Platform, To Launch Direct to Patient Digital Campaign to Increase Accessibility of CAMBIA® (diclofenac potassium) and SPRIX® (ketorolac tromethamine) [May-05-21 09:00AM] Assertio Reports First Quarter 2021 Financial Results [May-06-21 04:01PM]
11-03-2021	AH	4:00 PM ET (Mar 11)	ASRT	Assertio Holdings, Inc.	151.55	-0.20	-0.04	-2.65	Assertio Therapeutics EPS misses by $0.16, beats on revenue [3/11/2021 4:02 PM]	0.9799	0.03 (2.94%)	0.9150	-0.04 (-3.88%)	0.33 - 1.45	11,561,482	14,887,544	335,858
Assertio Therapeutics EPS misses by $0.16, beats on revenue [3/11/2021 4:02 PM] Assertio Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-11-21 04:01PM]
06-11-2020	PM	6:00 AM ET (Nov 6)	ASRT	Assertio Holdings, Inc.	69.75	-0.09	-0.05	0.05	Assertio Therapeutics EPS misses by $0.05, beats on revenue [11/6/2020 6:03 AM]	0.48	-0.19 (-28.36%)	0.66	-0.01 (-1.49%)	0.45 - 1.71	3,686,648	257,374	27,098

07-08-2020	PM	8:00 AM ET (Aug 7)	ASRT	Assertio Holdings, Inc.	95.00	-0.35	-0.12	-0.21	Assertio Therapeutics EPS misses by $0.23, misses on revenue [8/7/2020 6:05 AM]	0.79	-0.14 (-15.51%)	0.8577	-0.08 (-8.27%)	0.55 - 2.92	3,138,530	623,835	127,120